{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:54:51Z","timestamp":1791028491211,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.autrev.2026.104190","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:53:48Z","timestamp":1790783628000},"page":"104190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The lung as an autoimmune organ: From mucosal tolerance breach to AI-enabled interception"],"prefix":"10.1016","volume":"25","author":[{"given":"Paolo","family":"Ruggeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Manti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Danieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104190_bb0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41584-024-01154-0","article-title":"Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis","volume":"20","author":"Holers","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0015","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/acr.25347","article-title":"2023 American College of Rheumatology\/American College of Chest Physicians guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.autrev.2026.104190_bb0020","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/acr.25348","article-title":"2023 American College of Rheumatology\/American College of Chest Physicians guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104190_bb0025","doi-asserted-by":"crossref","first-page":"2402533","DOI":"10.1183\/13993003.02533-2024","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease","volume":"67","author":"Antoniou","year":"2026","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.autrev.2026.104190_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37720-5","article-title":"Interstitial lung disease diagnosis and prognosis using an AI system integrating longitudinal data","volume":"14","author":"Mei","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104190_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-2600(18)30286-8","article-title":"Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study","volume":"6","author":"Walsh","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1164\/rccm.202112-2684OC","article-title":"Deep learning-based outcome prediction in progressive fibrotic lung disease using high-resolution computed tomography","volume":"206","author":"Walsh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kead164","article-title":"Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis","volume":"63","author":"Le Gall","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104190_bb0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/rccm.202309-1692OC","article-title":"Machine learning of plasma proteomics classifies diagnosis of interstitial lung disease","volume":"210","author":"Huang","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0055","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104190_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope) - restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104190_bb0065","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","article-title":"Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104190_bb0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.40066","article-title":"Anti-citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients","volume":"69","author":"Demoruelle","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.41948","article-title":"Association of sputum neutrophil extracellular trap subsets with IgA anti-citrullinated protein antibodies in subjects at risk for rheumatoid arthritis","volume":"74","author":"Okamoto","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0080","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","article-title":"Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis","volume":"66","author":"Reynisdottir","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0090","doi-asserted-by":"crossref","unstructured":"Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183\u201394. https:\/\/doi.org\/10.1172\/JCI28756. 10.1172\/JCI28756.","DOI":"10.1172\/JCI28756"},{"key":"10.1016\/j.autrev.2026.104190_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/ijr.14.23","article-title":"The lung may play a role in the pathogenesis of rheumatoid arthritis","volume":"9","author":"Demoruelle","year":"2014","journal-title":"Int J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0100","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104190_bb0105","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0110","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.autrev.2026.104190_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17476348.2024.2374910","article-title":"Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis\/dermatomyositis (PM\/DM-ILD): development of expert consensus-based clinical algorithms","volume":"18","author":"Kondoh","year":"2024","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104190_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-025-03626-4","article-title":"The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis","volume":"27","author":"Zheng","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104190_bb0125","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104190_bb0130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104190_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104190_bb0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.43366","article-title":"A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis","volume":"78","author":"Deane","year":"2026","journal-title":"Arthritis Rheumatol"},{"issue":"17","key":"10.1016\/j.autrev.2026.104190_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14176164","article-title":"High-resolution CT findings in interstitial lung disease associated with connective tissue diseases: differentiating patterns for clinical practice-a systematic review with meta-analysis","volume":"14","author":"Drimus","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0150","doi-asserted-by":"crossref","unstructured":"Ikdahl E, Mangseth H. Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening. Scand J Rheumatol 202655(1):59\u201367. https:\/\/doi.org\/10.1080\/03009742.2025.2538946.","DOI":"10.1080\/03009742.2025.2538946"},{"key":"10.1016\/j.autrev.2026.104190_bb0155","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0160","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0165","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104190_bb0170","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104190_bb0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"Tsuji","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0180","article-title":"Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104190_bb0185","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.21037\/qims-24-595","article-title":"Development of a machine learning model in prediction of the rapid progression of interstitial lung disease in patients with idiopathic inflammatory myopathy","volume":"14","author":"Qiang","year":"2024","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.autrev.2026.104190_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12890-022-01868-5","article-title":"Interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224772","article-title":"Quantitative assessment of interstitial lung disease in Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Guisado-Vasco","year":"2019","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.autrev.2026.104190_bb0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RHU.0000000000000291","article-title":"Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: focus on outcome and therapy","volume":"21","author":"Ednalino","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2026.104190_bb0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104190_bb0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0220","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/art.70237","article-title":"Expert perspectives: defining and managing progressive pulmonary fibrosis in systemic sclerosis","author":"Benfaremo","year":"2026","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104190_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2026.104092","article-title":"Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: phenotypes matter","volume":"25","author":"Marchetti","year":"2026","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0235","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0240","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (scleroderma lung study II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0245","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0250","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2213-2600(22)00359-9","article-title":"Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): a randomised, double-blind, double-dummy, phase 2b trial","volume":"11","author":"Maher","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0260","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.autrev.2026.104190_bb0265","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/a-2737-7719","article-title":"Autoimmune pulmonary alveolar proteinosis","volume":"47","author":"Papiris","year":"2026","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104190_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/acr.25423","article-title":"Environment, lifestyles, and climate change: the many nongenetic contributors to the long and winding road to autoimmune diseases","volume":"77","author":"Miller","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2026.104190_bb0275","article-title":"Amphibole asbestos as an environmental trigger for systemic autoimmune diseases","volume":"23","author":"Pfau","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103584","article-title":"Exposome: epigenetics and autoimmune diseases","volume":"23","author":"Danieli","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103607","article-title":"The role of microbiota and oxidative stress axis and the impact of intravenous immunoglobulin in systemic lupus erythematosus","volume":"23","author":"Danieli","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103308","article-title":"Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies","volume":"22","author":"Danieli","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"17","key":"10.1016\/j.autrev.2026.104190_bb0295","article-title":"Piezo1 in respiratory diseases: mechanotransduction, cell-specific functions, and translational implications","volume":"1","author":"Tao","year":"2026","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2026.104190_bb0300","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2018-214865","article-title":"Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease","volume":"78","author":"Valenzi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104190_bb0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/annrheumdis-2021-220493","article-title":"Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease","volume":"81","author":"Jung","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104190_bb0310","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0315","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","article-title":"An integrated cell atlas of the lung in health and disease","volume":"29","author":"Sikkema","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0320","doi-asserted-by":"crossref","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.autrev.2026.104190_bb0325","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ard.2025.04.025","article-title":"Spatial multiomics decipher fibroblast-macrophage dynamics in systemic sclerosis","volume":"84","author":"Li","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104190_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34145-4","article-title":"Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications","volume":"13","author":"Ye","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.autrev.2026.104190_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311357","article-title":"Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease","volume":"19","author":"d\u2019Alessandro","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2026.104190_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103710","article-title":"Intravenous immunoglobulin as a therapy for autoimmune conditions","volume":"24","author":"Danieli","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103353","article-title":"A machine learning analysis to evaluate the outcome measures in inflammatory myopathies","volume":"22","author":"Danieli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103105","article-title":"A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases","volume":"21","author":"Danieli","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104190_bb0355","doi-asserted-by":"crossref","DOI":"10.2196\/59187","article-title":"Integrating clinical data and medical imaging in lung Cancer: feasibility study using the observational medical outcomes partnership common data model extension","volume":"12","author":"Ji","year":"2024","journal-title":"JMIR Med Inform"},{"issue":"1","key":"10.1016\/j.autrev.2026.104190_bb0360","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbag073","article-title":"Computational approaches to multimodal data integration in rheumatoid arthritis: from data landscape to clinical translation","volume":"27","author":"Xu","year":"2026","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.autrev.2026.104190_bb0365","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2026.104190_bb0370","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41591-020-1034-x","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"26","author":"Liu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0375","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/S2589-7500(20)30219-3","article-title":"Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension","volume":"2","author":"Rivera","year":"2020","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.autrev.2026.104190_bb0380","article-title":"Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"18","author":"Vasey","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2026.104190_bb0385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0390","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2026.104190_bb0395","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.2020200029","article-title":"Checklist for artificial intelligence in medical imaging (CLAIM): a guide for authors and reviewers","volume":"2","author":"Mongan","year":"2020","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.autrev.2026.104190_bb0400","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081554","article-title":"FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare","volume":"388","author":"Lekadir","year":"2025","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.autrev.2026.104190_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000607","article-title":"Ethical, legal, and social issues (ELSI) and reporting guidelines of AI research in healthcare","volume":"3","author":"Kameyama","year":"2024","journal-title":"PLoS Digit Health"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226002041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226002041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:23:00Z","timestamp":1791026580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226002041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1568997226002041"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104190","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The lung as an autoimmune organ: From mucosal tolerance breach to AI-enabled interception","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104190"}}